bell
The current prices are delayed by 15 mins, login to check live prices.
Samrat Pharmachem Ltd share price logo

Samrat Pharmachem Ltd

(530125)

₹4453.95%

as on 04:01PM, 21 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Samrat Pharmachem Ltd Performance

  • Day's Low

    Day's High

    ₹440.15
    ₹479.95
  • 52 Week's Low

    52 Week's High

    ₹320
    ₹646
1 Month Return-7.34 %
3 Month Return+ 15.22 %
1 Year Return+ 25.78 %
Previous Close₹463.30
Open₹479.95
Volume4,190.00
Upper Circuit-
Lower Circuit-
Market Cap₹143.16Cr

Samrat Pharmachem Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹143.16 Cr
P/B Ratio1.59
EPS0
Dividend Yield0
SectorPharmaceuticals
ROE3.37

Samrat Pharmachem Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹143.16 Cr73.55%0.56NANA
NA₹64.17 Cr258.28%0.50NANA
NA₹123.98 Cr53.7%0.69NANA
NA₹94.27 Cr188.71%0.51NANA
NA₹1,388.42 Cr84.92%0.51₹25 Cr₹212 Cr

About Samrat Pharmachem Ltd

Samrat Pharmachem Ltd is a chemical manufacturing company established in 1992 with its headquarters in India. Over the years, the company has successfully diversified and branched out into pharmaceuticals and pharmaceutical bulk drugs by forming a new 100% subsidiary, Samrat Remedies Limited, in 2003. Samrat Remedies Limited is exclusively devoted to the manufacturing of pharmaceutical bulk drugs and chemicals. Samrat Pharmachem Ltd prides itself on offering customers with premium products and superior quality services along with its commitment to innovation to find solutions for the world's toughest problems.

Share Price: ₹445.00 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹143.16Cr as of today
Chairperson Name: Lalit Mehta
OrganisationSamrat Pharmachem Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Samrat Pharmachem Ltd

  • Samrat Pharmachem Reports Strong Q4 Results - 02 Jun, 2024

    Samrat Pharmachem reports strong Q4 results with a 19.77% increase in revenue and ₹1.4cr profit compared to a loss of ₹0.74cr in the previous year. The EPS is ₹4.52 for Q4, up by 287.52% YoY.

Insights on Samrat Pharmachem Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 48.64% to 48.95% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, Samrat Pharma stock has moved up by 15.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 36.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 32.8%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 47.91% to 47.59% in Sep 2024 quarter

Samrat Pharmachem Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹57.49Cr (-)₹84.76Cr (↑47.43%)₹117.01Cr (↑38.05%)₹122.18Cr (↑4.42%)
Total Liabilities₹27.85Cr (-)₹37.94Cr (↑36.23%)₹53.87Cr (↑41.99%)₹57.18Cr (↑6.14%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹1.33Cr (-)₹4.80Cr (↓460.90%)₹17.47Cr (↑263.96%)-₹9.44Cr (↓154.04%)₹9.41Cr (↓199.68%)
0

Samrat Pharmachem Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
48.95%
0.65
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
47.59%
-0.66
Others
3.45%
0.00

Samrat Pharmachem Ltd Key Indicators

Details20202021202220232024
Return On Equity %19.1119.7644.9430.253.37

Samrat Pharmachem Ltd Earnings and Dividends

  • Samrat Pharmachem Ltd Earnings Results

    Samrat Pharmachem Ltd’s net profit jumped 1500% since last year same period to ₹2.66Cr in the Q2 2024-2025. On a quarterly growth basis, Samrat Pharmachem Ltd has generated 28.5% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Samrat Pharmachem Ltd Dividends May,2024

    In the quarter ending March 2024, Samrat Pharmachem Ltd has declared dividend of ₹1 - translating a dividend yield of 0.43%.

    Read More about Dividends

Samrat Pharmachem Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Samrat Pharmachem Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Samrat Pharmachem Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Samrat Pharmachem Ltd shares.

Samrat Pharmachem Ltd (530125) share price today is ₹445

Samrat Pharmachem Ltd is not listed on NSE

Samrat Pharmachem Ltd is listed on BSE

  • Today’s highest price of Samrat Pharmachem Ltd is ₹479.95.
  • Today’s lowest price of Samrat Pharmachem Ltd is ₹440.15.

Today’s traded volume of Samrat Pharmachem Ltd(530125) is 4,190.00.

Today’s market capitalisation of Samrat Pharmachem Ltd(530125) is ₹143.16Cr.

Samrat Pharmachem Ltd(530125Price
52 Week High
₹646
52 Week Low
₹320

Samrat Pharmachem Ltd(530125) share price is ₹445. It is down -31.11% from its 52 Week High price of ₹646

Samrat Pharmachem Ltd(530125) share price is ₹445. It is up 39.06% from its 52 Week Low price of ₹320

Samrat Pharmachem Ltd(530125Returns
1 Day Returns
-18.3%
1 Month Returns
-7.34%
3 Month Returns
15.22%
1 Year Returns
25.78%